@article{HBSN4261,
author = {James J. Harding and Ghassan K. Abou-Alfa},
title = {Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {3},
number = {4},
year = {2014},
keywords = {},
abstract = {A small proportion of patients with advanced hepatocellular carcinoma harbor FGF3/4 gene amplifications in an 11q13 amplicon. A recent report suggests that the presence of this alteration might enrich for sensitivity to sorafenib. Further, there is growing evidence that interference with the FGF/FGFR axis has therapeutic potential in patients with advanced hepatocellular carcinoma.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/4261}
}